Literature DB >> 3969238

Paraaortic lymph node radiotherapy in cancer of the uterine corpus.

R A Potish, L B Twiggs, L L Adcock, J E Savage, S H Levitt, K A Prem.   

Abstract

From 1973 through 1982, 48 women received 4500 to 5075 rads to the paraaortic lymph nodes as part of their primary management for cancer of the uterine corpus. One patient developed severe enteric morbidity. Five-year survival rates were 52% in the total group, 57% in clinically staged patients, and 47% in surgically staged patients. Patients with surgically confirmed pelvic lymphatic spread had a five-year survival rate of 67%. Patients with surgically confirmed paraaortic spread alone or pelvic and paraaortic spread had five-year survival rates of 47 and 43%, respectively. Eighty-eight percent of recurrences were outside of the radiation portals. In contradistinction to much of the last decade's literature, radiation therapy has salvaged a substantial fraction of patients with nodal metastases, and morbidity rates have been acceptable.

Entities:  

Mesh:

Year:  1985        PMID: 3969238

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  5 in total

Review 1.  Pathophysiology and management of endometrial hyperplasia and carcinoma.

Authors:  Y S Fu; J C Gambone; J S Berek
Journal:  West J Med       Date:  1990-07

Review 2.  Treatment for advanced and recurrent endometrial carcinoma: combined modalities.

Authors:  J Alejandro Rauh-Hain; Marcela G Del Carmen
Journal:  Oncologist       Date:  2010-07-21

3.  Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy.

Authors:  T Onda; H Yoshikawa; K Mizutani; M Mishima; H Yokota; H Nagano; Y Ozaki; A Murakami; K Ueda; Y Taketani
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

4.  The impact of the absolute number and ratio of positive lymph nodes on survival of endometrioid uterine cancer patients.

Authors:  J K Chan; D S Kapp; M K Cheung; K Osann; J Y Shin; D Cohn; P L Seid
Journal:  Br J Cancer       Date:  2007-07-31       Impact factor: 7.640

5.  Lymphadenectomy and adjuvant therapy in endometrial carcinoma: role of adjuvant chemotherapy.

Authors:  I Otsuka; T Kubota; T Aso
Journal:  Br J Cancer       Date:  2002-08-12       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.